Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Respiratory Syncytial Virus Topic Center

Featured Article

News
CDC Recommends RSV Vaccination for Older Adults Who Have Not Received It
08/07/2024
Studies are currently investigating how long protection lasts after receiving the respiratory syncytial virus (RSV) vaccine.
Studies are currently investigating how long protection lasts after receiving the respiratory syncytial virus (RSV) vaccine.
Studies are currently...
08/07/2024
Pharmacy Learning Network
News
Officials Will Continue to Assess Guillain-Barré Syndrome Risk After RSV Vaccine
06/12/2024
Jolynn Tumolo
Consistent with prelicensure clinical trials, nearly a year of respiratory syncytial virus (RSV) vaccine use in US older adults showed higher-than-expected rates of Guillain-Barré syndrome after RSV vaccination compared with after COVID-19...
Consistent with prelicensure clinical trials, nearly a year of respiratory syncytial virus (RSV) vaccine use in US older adults showed higher-than-expected rates of Guillain-Barré syndrome after RSV vaccination compared with after COVID-19...
Consistent with prelicensure...
06/12/2024
Pharmacy Learning Network
News
Hospitalized Older Adults With RSV Commonly Experience Severe Acute Cardiac Events, Study Finds
05/30/2024
Lisa Kuhns, PhD
Hospitalized older adults with respiratory syncytial virus (RSV) often have acute cardiac events that are associated with severe clinical outcomes, according to a study published in JAMA Network Open.
Hospitalized older adults with respiratory syncytial virus (RSV) often have acute cardiac events that are associated with severe clinical outcomes, according to a study published in JAMA Network Open.
Hospitalized older adults with...
05/30/2024
Pharmacy Learning Network
News
Pre-RSV Vaccine Era: RSV Severity Matches or Exceeds COVID-19 and Influenza in Hospitalized Patients
05/16/2024
Lisa Kuhns, PhD
Before the vaccine for respiratory syncytial virus (RSV), the virus was as severe as COVID-19 or influenza among unvaccinated patients, but more severe than COVID-19 or influenza among vaccinated patients hospitalized with those diseases,...
Before the vaccine for respiratory syncytial virus (RSV), the virus was as severe as COVID-19 or influenza among unvaccinated patients, but more severe than COVID-19 or influenza among vaccinated patients hospitalized with those diseases,...
Before the vaccine for...
05/16/2024
Pharmacy Learning Network
News
Outcomes Worse in Adults Hospitalized With RSV than Influenza
04/09/2024
Jolynn Tumolo
US adults hospitalized with respiratory syncytial virus (RSV) were more likely to have cardiopulmonary conditions, undergo longer hospital stays, and need mechanical ventilation compared with those hospitalized with influenza, according to a...
US adults hospitalized with respiratory syncytial virus (RSV) were more likely to have cardiopulmonary conditions, undergo longer hospital stays, and need mechanical ventilation compared with those hospitalized with influenza, according to a...
US adults hospitalized with...
04/09/2024
Pharmacy Learning Network
News
Just 1 in 10 Older Americans Vaccinated Against RSV by Fall 2023
04/02/2024
Jolynn Tumolo
Most surveyed Americans older than 60 said they were unlikely to seek out respiratory syncytial virus (RSV) vaccination for the 2023-2024 season, according to a study published online in Health Affairs Scholar.
Most surveyed Americans older than 60 said they were unlikely to seek out respiratory syncytial virus (RSV) vaccination for the 2023-2024 season, according to a study published online in Health Affairs Scholar.
Most surveyed Americans older...
04/02/2024
Pharmacy Learning Network
News
Complex Dynamics of the Respiratory Syncytial Virus (RSV) Surge
01/18/2024

Lisa Kuhns, PhD

Lisa Kuhns, PhD
Nonviral factors may have also contributed to the surge, including changes in population immunity due to altered RSV dynamics resulting from interventions during the COVID-19 pandemic.
Nonviral factors may have also contributed to the surge, including changes in population immunity due to altered RSV dynamics resulting from interventions during the COVID-19 pandemic.
Nonviral factors may have also...
01/18/2024
Pharmacy Learning Network
News
RSV Can Infect Nerve Cells, Triggering Damage
01/15/2024
Jolynn Tumolo
“Until this study, the theory was that the inflammatory response was indirectly activating the nerves,” said study corresponding author Giovanni Piedimonte, MD, FAAP, FCCP, vice president for research and professor of pediatrics,...
“Until this study, the theory was that the inflammatory response was indirectly activating the nerves,” said study corresponding author Giovanni Piedimonte, MD, FAAP, FCCP, vice president for research and professor of pediatrics,...
“Until this study, the theory...
01/15/2024
Pharmacy Learning Network
News
Debate Emerges Over Pfizer's Disclosure of Safety Signal in RSV Vaccine Trial
11/20/2023
Hannah Musick
An investigation by The BMJ has Pfizer facing criticism for failing to inform pregnant women participating in an RSV vaccine trial of the suspension of a similar GSK trial due to a safety concern regarding preterm birth.
An investigation by The BMJ has Pfizer facing criticism for failing to inform pregnant women participating in an RSV vaccine trial of the suspension of a similar GSK trial due to a safety concern regarding preterm birth.
An investigation by The BMJ has...
11/20/2023
Pharmacy Learning Network
News
Balancing Potential Prevention Strategies for Respiratory Syncytial Virus With Continued Emphasis on Supportive Care as Optimal Treatment
11/15/2023

Lisa Kuhns, PhD

Lisa Kuhns, PhD
Specific therapies are lacking for treating respiratory syncytial virus (RSV), and while current prevention strategies offer great potential, supportive care remains the best treatment, according to a study published in Pathogens.
Specific therapies are lacking for treating respiratory syncytial virus (RSV), and while current prevention strategies offer great potential, supportive care remains the best treatment, according to a study published in Pathogens.
Specific therapies are lacking...
11/15/2023
Pharmacy Learning Network
Poll
Methods for Mitigating Respiratory Disease Transmission
11/13/2023
Learn more about EPA-approved DIY Indoor Air Filters. To learn more about infectious disease prevention, visit our Infectious Disease Topic Center. 
Learn more about EPA-approved DIY Indoor Air Filters. To learn more about infectious disease prevention, visit our Infectious Disease Topic Center. 
Learn more about...
11/13/2023
Pharmacy Learning Network

Newsfeed

News
CDC Recommends RSV Vaccination for Older Adults Who Have Not Received It
08/07/2024
Studies are currently investigating how long protection lasts after receiving the respiratory syncytial virus (RSV) vaccine.
Studies are currently investigating how long protection lasts after receiving the respiratory syncytial virus (RSV) vaccine.
Studies are currently...
08/07/2024
Pharmacy Learning Network
News
Officials Will Continue to Assess Guillain-Barré Syndrome Risk After RSV Vaccine
06/12/2024
Jolynn Tumolo
Consistent with prelicensure clinical trials, nearly a year of respiratory syncytial virus (RSV) vaccine use in US older adults showed higher-than-expected rates of Guillain-Barré syndrome after RSV vaccination compared with after COVID-19...
Consistent with prelicensure clinical trials, nearly a year of respiratory syncytial virus (RSV) vaccine use in US older adults showed higher-than-expected rates of Guillain-Barré syndrome after RSV vaccination compared with after COVID-19...
Consistent with prelicensure...
06/12/2024
Pharmacy Learning Network
News
Hospitalized Older Adults With RSV Commonly Experience Severe Acute Cardiac Events, Study Finds
05/30/2024
Lisa Kuhns, PhD
Hospitalized older adults with respiratory syncytial virus (RSV) often have acute cardiac events that are associated with severe clinical outcomes, according to a study published in JAMA Network Open.
Hospitalized older adults with respiratory syncytial virus (RSV) often have acute cardiac events that are associated with severe clinical outcomes, according to a study published in JAMA Network Open.
Hospitalized older adults with...
05/30/2024
Pharmacy Learning Network
News
Pre-RSV Vaccine Era: RSV Severity Matches or Exceeds COVID-19 and Influenza in Hospitalized Patients
05/16/2024
Lisa Kuhns, PhD
Before the vaccine for respiratory syncytial virus (RSV), the virus was as severe as COVID-19 or influenza among unvaccinated patients, but more severe than COVID-19 or influenza among vaccinated patients hospitalized with those diseases,...
Before the vaccine for respiratory syncytial virus (RSV), the virus was as severe as COVID-19 or influenza among unvaccinated patients, but more severe than COVID-19 or influenza among vaccinated patients hospitalized with those diseases,...
Before the vaccine for...
05/16/2024
Pharmacy Learning Network
News
Outcomes Worse in Adults Hospitalized With RSV than Influenza
04/09/2024
Jolynn Tumolo
US adults hospitalized with respiratory syncytial virus (RSV) were more likely to have cardiopulmonary conditions, undergo longer hospital stays, and need mechanical ventilation compared with those hospitalized with influenza, according to a...
US adults hospitalized with respiratory syncytial virus (RSV) were more likely to have cardiopulmonary conditions, undergo longer hospital stays, and need mechanical ventilation compared with those hospitalized with influenza, according to a...
US adults hospitalized with...
04/09/2024
Pharmacy Learning Network
News
Just 1 in 10 Older Americans Vaccinated Against RSV by Fall 2023
04/02/2024
Jolynn Tumolo
Most surveyed Americans older than 60 said they were unlikely to seek out respiratory syncytial virus (RSV) vaccination for the 2023-2024 season, according to a study published online in Health Affairs Scholar.
Most surveyed Americans older than 60 said they were unlikely to seek out respiratory syncytial virus (RSV) vaccination for the 2023-2024 season, according to a study published online in Health Affairs Scholar.
Most surveyed Americans older...
04/02/2024
Pharmacy Learning Network
News
Complex Dynamics of the Respiratory Syncytial Virus (RSV) Surge
01/18/2024

Lisa Kuhns, PhD

Lisa Kuhns, PhD
Nonviral factors may have also contributed to the surge, including changes in population immunity due to altered RSV dynamics resulting from interventions during the COVID-19 pandemic.
Nonviral factors may have also contributed to the surge, including changes in population immunity due to altered RSV dynamics resulting from interventions during the COVID-19 pandemic.
Nonviral factors may have also...
01/18/2024
Pharmacy Learning Network
News
RSV Can Infect Nerve Cells, Triggering Damage
01/15/2024
Jolynn Tumolo
“Until this study, the theory was that the inflammatory response was indirectly activating the nerves,” said study corresponding author Giovanni Piedimonte, MD, FAAP, FCCP, vice president for research and professor of pediatrics,...
“Until this study, the theory was that the inflammatory response was indirectly activating the nerves,” said study corresponding author Giovanni Piedimonte, MD, FAAP, FCCP, vice president for research and professor of pediatrics,...
“Until this study, the theory...
01/15/2024
Pharmacy Learning Network
News
Debate Emerges Over Pfizer's Disclosure of Safety Signal in RSV Vaccine Trial
11/20/2023
Hannah Musick
An investigation by The BMJ has Pfizer facing criticism for failing to inform pregnant women participating in an RSV vaccine trial of the suspension of a similar GSK trial due to a safety concern regarding preterm birth.
An investigation by The BMJ has Pfizer facing criticism for failing to inform pregnant women participating in an RSV vaccine trial of the suspension of a similar GSK trial due to a safety concern regarding preterm birth.
An investigation by The BMJ has...
11/20/2023
Pharmacy Learning Network
News
Balancing Potential Prevention Strategies for Respiratory Syncytial Virus With Continued Emphasis on Supportive Care as Optimal Treatment
11/15/2023

Lisa Kuhns, PhD

Lisa Kuhns, PhD
Specific therapies are lacking for treating respiratory syncytial virus (RSV), and while current prevention strategies offer great potential, supportive care remains the best treatment, according to a study published in Pathogens.
Specific therapies are lacking for treating respiratory syncytial virus (RSV), and while current prevention strategies offer great potential, supportive care remains the best treatment, according to a study published in Pathogens.
Specific therapies are lacking...
11/15/2023
Pharmacy Learning Network
News
Supplements Recalled for Containing Drug Ingredients
08/08/2024
SoloVital.com, based in Chula Vista, California, is recalling all lots of the dietary supplement Umary Acido Hialuronico, Suplemento Alimenticio.
SoloVital.com, based in Chula Vista, California, is recalling all lots of the dietary supplement Umary Acido Hialuronico, Suplemento Alimenticio.
SoloVital.com, based in Chula...
08/08/2024
Pharmacy Learning Network
News
More Hypokalemia Capsules Under Class I Recall
08/08/2024
American Health Packaging, on behalf of BluePoint Laboratories, is recalling several lots of potassium chloride extended-release capsules for failing to meet dissolution specifications.
American Health Packaging, on behalf of BluePoint Laboratories, is recalling several lots of potassium chloride extended-release capsules for failing to meet dissolution specifications.
American Health Packaging, on...
08/08/2024
Pharmacy Learning Network
News
Mislabeled Drug Under Class I Recall
08/08/2024
Endo Pharmaceuticals Inc. is recalling clonazepam orally disintegrating tablets because some cartons were mislabeled with an incorrect strength.
Endo Pharmaceuticals Inc. is recalling clonazepam orally disintegrating tablets because some cartons were mislabeled with an incorrect strength.
Endo Pharmaceuticals Inc. is...
08/08/2024
Pharmacy Learning Network
News
CDC Recommends RSV Vaccination for Older Adults Who Have Not Received It
08/07/2024
Studies are currently investigating how long protection lasts after receiving the respiratory syncytial virus (RSV) vaccine.
Studies are currently investigating how long protection lasts after receiving the respiratory syncytial virus (RSV) vaccine.
Studies are currently...
08/07/2024
Pharmacy Learning Network
News
Label Error Prompts Homeopathic Kit Recall
08/01/2024
Homeopathic kits distributed throughout the United States are being recalled because of a labeling mix-up.
Homeopathic kits distributed throughout the United States are being recalled because of a labeling mix-up.
Homeopathic kits distributed...
08/01/2024
Pharmacy Learning Network
News
SNRI Recalled
08/01/2024
Zydus Pharmaceuticals Inc. is recalling 90-count and 1000-count bottles of venlafaxine hydrochloride extended-release capsules for failing to meet dissolution specifications.
Zydus Pharmaceuticals Inc. is recalling 90-count and 1000-count bottles of venlafaxine hydrochloride extended-release capsules for failing to meet dissolution specifications.
Zydus Pharmaceuticals Inc. is...
08/01/2024
Pharmacy Learning Network
News
Subpotent OTC Pain Products Pulled
08/01/2024
Two over-the-counter pain relief products are being recalled for containing inaccurate levels of menthol.
Two over-the-counter pain relief products are being recalled for containing inaccurate levels of menthol.
Two over-the-counter pain relief...
08/01/2024
Pharmacy Learning Network
News
Class I Recall for Contaminated Mouth Spray
07/25/2024
Microbial contamination has prompted HomeoCare Laboratories Inc. to recall 31 811 bottles of StellaLife VEGA Oral Care spray.
Microbial contamination has prompted HomeoCare Laboratories Inc. to recall 31 811 bottles of StellaLife VEGA Oral Care spray.
Microbial contamination has...
07/25/2024
Pharmacy Learning Network
News
Hypokalemia Capsules Under Class I Recall
07/25/2024
More than 50 lots of potassium chloride extended-release capsules sold by Glenmark Pharmaceuticals Inc. USA are under a Class I recall for failing to meet dissolution specifications.
More than 50 lots of potassium chloride extended-release capsules sold by Glenmark Pharmaceuticals Inc. USA are under a Class I recall for failing to meet dissolution specifications.
More than 50 lots of potassium...
07/25/2024
Pharmacy Learning Network
News
Prostate Medication Recalled
07/25/2024
Viatris Inc. is recalling more than 16 000 bottles of Cardura XL (doxazosin) extended-release tablets for failing to meet impurity/degradation specifications.
Viatris Inc. is recalling more than 16 000 bottles of Cardura XL (doxazosin) extended-release tablets for failing to meet impurity/degradation specifications.
Viatris Inc. is recalling more...
07/25/2024
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement